Skip to main content
Clinical Trials/NCT04450381
NCT04450381CompletedNot Applicable

Noninvasive Hemoglobin Testing in Prospective Blood Donors

Masimo Corporation1 site in 1 country131 target enrollmentStarted: June 23, 2020Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
131
Locations
1
Primary Endpoint
Rad-67 Sensitivity

Study Overview

Brief Summary

The objective of this clinical investigation is to evaluate the pulse oximeter devices for screening prospective blood donors. The purpose study is to report on the accuracy of noninvasive hemoglobin (SpHb) as compared to hemoglobin measurements obtained from a laboratory hematology analyzer in a blood donation setting.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Other
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •At least 18 years of age
  • •Weight at least 110 pounds
  • •Subjects with the intention of being screened for eligibility to donate blood
  • •The subject has given written informed consent to participate in the study

Exclusion Criteria

  • •Subjects with skin abnormalities at the planned application sites that may interfere with sensor application, per directions-for-use (DFU) or trans-illumination of the site, such as burns, scar tissue, infections, abnormalities, etc.
  • •Subjects unwilling and/or unable to remove nail polish or acrylic nails
  • •Subjects with blood cancers such as leukemia
  • •Subjects with hemoglobin disorders such as sickle-cell anemia and thalassemia
  • •Subjects with known history of infectious diseases such as HIV/AIDS, syphilis, hepatitis, etc.
  • •Subjects with self-disclosed/known pregnancy at the time of enrollment
  • •Subjects deemed not suitable for the study at the discretion of the investigator
  • •Excessive motion includes postural changes, making hand gestures, involuntary muscular movements, etc.

Arms & Interventions

Test subjects

Experimental

All subjects are enrolled and receive Rad-67 Pulse oximeter & DCI Mini sensor for measurement of hemoglobin.

Intervention: Rad-67 Pulse oximeter & DCI Mini sensor (Device)

Outcomes

Primary Outcomes

Rad-67 Sensitivity

Time Frame: Up to one hour per subject

Sensitivity of the the Rad-67 will be determined for its use in a blood donation center

Rad-67 Specificity

Time Frame: Up to one hour per subject

Specificity of the the Rad-67 will be determined for its use in a blood donation center

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Noninvasive Hemoglobin Testing,... | Clinical Trial